🏅 Congratulations to Dr. @NickLeeper78 on receiving the 2025 ATVB Special Recognition Award in Arteriosclerosis from @American_Heart! Dr. Leeper will be honored at #AHA2025 with the award in New Orleans this November.
🔗 Read the full story: https://t.co/zJCWlg8zhu
🔬New in @JVascSurg from Dr. @CabotMD: TEVAR for blunt thoracic aortic injury performed with portable C-Arm imaging has higher complication rates—including all reported strokes—vs hybrid OR or IR suite.
🔗: https://t.co/cRhRfpa8J6
🧬 Genome-wide study from Dr. Shaunak Adkar in @Circ_Gen identifies 5 novel loci linked to intracranial aneurysm and implicates pericytes & smooth muscle cells—pointing to matrix deficits as a potential driver, independent of smoking or hypertension.
🔗: https://t.co/xB5SP3hZ8C
📰 Released at #VAM25: A 20-year Stanford study shows 82% of athletes returned to prior level of athletics after treatment for functional popliteal artery entrapment syndrome (FPAES). @JVascSurg#VascSurg#SportsMedicine#FPAES
🔗Full press release: https://t.co/28oqFVEQpt
@VascularSVS From cutting-edge genomics and AI-driven risk prediction to new approaches in trauma, dialysis access, complex aortic repair and limb salvage—our team is pushing the field forward. 💪🩺🧠 #VAM25
4-compartment fasciotomy should be considered in all FPAES patients at time of decompression, regardless of pre-op pressures, as FPAES exists on a spectrum with CECS. Males had better outcomes than females. More to come from our group!
@StanfordVasc
https://t.co/34UPro6wAO Popliteal Entrapment in Athletes treated with concurrent fasciotomies: is this the new standard? #VAM2025#VAM25 Here is the latest in our simultaneous presentations and publications of articles for@JVascSurg
Spoiler alert: complications are almost 4 times more likely when C-Arm is used compared to a fixed imaging system(hybrid OR or IR suite).
All providers performing TEVAR for BTAI should make all effort to utilize our more advanced imaging systems.
Does the equipment change the outcomes in #BTAI? Check out the data from our next simultaneous presentation #VAM2025#VAM25 and publication. #Simulpub https://t.co/0e8AqoEauL
🎉🎉 It’s a Match!
We’re thrilled to announce that Dr. Davis H. Payne has matched into the 2026–2028 Vascular Surgery Fellowship!
Welcome to the Farm—we can’t wait for you to join us next year! 👏🩺
Very strong showing from our team at #SCVS2025 in Austin! 👏
Congratulations to Drs. Fereydooni, @CabotMD, @KeyureeS, Zahiri & Ho for their stellar presentations.
Special shoutout to Dr. @CabotMD for winning 2nd place in the Karmody Poster Competition! 🏆
@SCVS1969
🎉 Match Day 2025
We're excited to welcome Farwah Iqbal and Valentyna (Valia) Kostiuk to the Stanford Vascular Surgery fam! Congratulations and welcome to the farm! 🌲
#Match2025
⭐️ Dr. John Cabot, PGY4, presented "A Shocking Solution for Calcific Stenosis of the Aorta: Intravascular lithotripsy for severe aortic occlusive disease in patient with Takayasu’s Arteritis."
@SWexner@StanfordSurgery@SurgJournal Our pleasure! Appreciate the invitation to contribute and work with @CabotMD to describe metrics beyond AUC that should be considered for predictive modeling. Exciting that @SurgJournal is publishing a series of edu articles on machine learning/AI 🦾🤖
Hey @FutureVascSurgn ! Are you an MS4 applying vascular surgery this cycle? Interested in doing an away rotation @StanfordVasc? Feel free to DM me with any questions you might have, or just to say hi! We can’t wait to meet you ✨🪢🦵
If we want the best possible healthcare, then we need to allow doctors (not insurers, private equity, etc) to practice medicine. https://t.co/ZAXezlHv8v @nytimes
Shaunak Adkar, MD presenting his work with @sternvascular looking at reintervention rates after carotid revascularization strategies. Lower rates of reintervention and TCAR compared to transfemoral stenting. @VAM23@StanfordSurgery
Incoming intern @KeyureeS presenting her work with Cassius Iyad Ochoa Chaar, MD looking at sex differences in reinterventions after lower extremity revascularization. Females had more reinterventions with no changes in long-term mortality or amputation risk. @StanfordSurgery
#VAM23 Grateful for the opportunity to present our findings that CHF is not a risk factor for AVF patency loss in a session with colleagues from around the world!
@michaelsgroi15@biancamulaney@StanfordVasc